Infectious Diseases, Department of Systems Medicine, Tor Vergata University, Rome, Italy.
Infectious Disease Clinic, Policlinico Tor Vergata, Rome, Italy.
BMC Infect Dis. 2024 Jan 20;24(1):109. doi: 10.1186/s12879-024-08995-w.
Actinomyces turicensis is rarely responsible of clinically relevant infections in human. Infection is often misdiagnosed as malignancy, tuberculosis, or nocardiosis, therefore delaying the correct identification and treatment. Here we report a case of a 55-year-old immunocompetent adult with brain abscess caused by A. turicensis. A systematic review of A. turicensis infections was performed.
A systematic review of the literature was performed according to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines. The databases MEDLINE, Embase, Web of Science, CINAHL, Clinicaltrials.gov and Canadian Agency for Drugs and Technology in Health (CADTH) were searched for all relevant literature.
Search identified 47 eligible records, for a total of 67 patients. A. turicensis infection was most frequently reported in the anogenital area (n = 21), causing acute bacterial skin and skin structure infections (ABSSSI) including Fournier's gangrene (n = 12), pulmonary infections (n = 8), gynecological infections (n = 6), cervicofacial district infections (n = 5), intrabdominal or breast infections (n = 8), urinary tract infections (n = 3), vertebral column infections (n = 2) central nervous system infections (n = 2), endocarditis (n = 1). Infections were mostly presenting as abscesses (n = 36), with or without concomitant bacteremia (n = 7). Fever and local signs of inflammation were present in over 60% of the cases. Treatment usually involved surgical drainage followed by antibiotic therapy (n = 51). Antimicrobial treatments most frequently included amoxicillin (+clavulanate), ampicillin/sulbactam, metronidazole or cephalosporins. Eighty-nine percent of the patients underwent a full recovery. Two fatal cases were reported.
To the best of our knowledge, we hereby present the first case of a brain abscess caused by A. turicensis and P. mirabilis. Brain involvement by A. turicensis is rare and may result from hematogenous spread or by dissemination of a contiguous infection. The infection might be difficult to diagnose and therefore treatment may be delayed. Nevertheless, the pathogen is often readily treatable. Diagnosis of actinomycosis is challenging and requires prompt microbiological identification. Surgical excision and drainage and antibiotic treatment usually allow for full recovery.
土耳其拟杆菌很少引起人类的临床相关感染。感染常被误诊为恶性肿瘤、结核病或诺卡氏菌病,从而导致正确的识别和治疗被延误。本文报告了一例 55 岁免疫功能正常的成人因土耳其拟杆菌引起的脑脓肿。对土耳其拟杆菌感染进行了系统评价。
根据系统评价和荟萃分析的首选报告项目(PRISMA)指南,对文献进行了系统评价。检索了 MEDLINE、Embase、Web of Science、CINAHL、Clinicaltrials.gov 和加拿大药物和技术评估机构(CADTH)数据库,以获取所有相关文献。
搜索共确定了 47 篇符合条件的记录,共计 67 例患者。土耳其拟杆菌感染最常发生在会阴部(n=21),引起急性细菌性皮肤和皮肤结构感染(ABSSSI),包括福尼尔坏疽(n=12)、肺部感染(n=8)、妇科感染(n=6)、颈面部感染(n=5)、腹内或乳房感染(n=8)、尿路感染(n=3)、脊椎感染(n=2)、中枢神经系统感染(n=2)、心内膜炎(n=1)。感染主要表现为脓肿(n=36),伴或不伴菌血症(n=7)。超过 60%的病例存在发热和局部炎症表现。治疗通常包括手术引流,然后进行抗生素治疗(n=51)。抗菌治疗最常包括阿莫西林(+克拉维酸)、氨苄西林/舒巴坦、甲硝唑或头孢菌素。89%的患者完全康复。报告了两例死亡病例。
据我们所知,本文首次报道了土耳其拟杆菌和奇异变形杆菌引起的脑脓肿。土耳其拟杆菌引起的脑受累很少见,可能是血行播散或邻近感染扩散所致。这种感染可能难以诊断,因此治疗可能会被延误。然而,病原体通常很容易治疗。放线菌病的诊断具有挑战性,需要及时进行微生物学鉴定。手术切除和引流以及抗生素治疗通常可使患者完全康复。